Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation

Clinical trial NCT02283294 · COMPLETED

Trial details

NCT number: NCT02283294
Sponsor: University of South Florida
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Transient Ischemic Attack Stroke Atrial Fibrillation

Start date: 2015-04-01
Primary completion: 2019-06-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.